These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14627096)

  • 21. Haplotype analysis of the MDR1 flanking region in the dog breed Elo.
    Fecht S; Wöhlke A; Distl O
    Berl Munch Tierarztl Wochenschr; 2008; 121(5-6):211-5. PubMed ID: 18557525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity.
    Sartor LL; Bentjen SA; Trepanier L; Mealey KL
    J Vet Intern Med; 2004; 18(1):117-8. PubMed ID: 14765742
    [No Abstract]   [Full Text] [Related]  

  • 23. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats.
    Merola VM; Eubig PA
    Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):991-1012. PubMed ID: 30139545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
    J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ivermectin toxicosis in dogs: a retrospective study.
    Merola V; Khan S; Gwaltney-Brant S
    J Am Anim Hosp Assoc; 2009; 45(3):106-11. PubMed ID: 19411645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1-1Δ.
    Heit MC; Mealey KL; King SB
    J Vet Pharmacol Ther; 2021 Sep; 44(5):705-713. PubMed ID: 34219249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
    Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD
    J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of prevalence, genetic aspects and adverse effects of the mdr1-1Delta mutation in dogs.
    Fecht S; Distl O
    Dtsch Tierarztl Wochenschr; 2008 Jun; 115(6):212-9. PubMed ID: 18605373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus.
    Blackhall WJ; Liu HY; Xu M; Prichard RK; Beech RN
    Mol Biochem Parasitol; 1998 Sep; 95(2):193-201. PubMed ID: 9803412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma.
    Gramer I; Kessler M; Geyer J
    Vet Comp Oncol; 2015 Dec; 13(4):363-72. PubMed ID: 23834200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canine mdr1 gene mutation in Japan.
    Kawabata A; Momoi Y; Inoue-Murayama M; Iwasaki T
    J Vet Med Sci; 2005 Nov; 67(11):1103-7. PubMed ID: 16327220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog.
    Xu M; Molento M; Blackhall W; Ribeiro P; Beech R; Prichard R
    Mol Biochem Parasitol; 1998 Mar; 91(2):327-35. PubMed ID: 9566525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the nt230(del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis.
    Geyer J; Klintzsch S; Meerkamp K; Wöhlke A; Distl O; Moritz A; Petzinger E
    J Vet Pharmacol Ther; 2007 Oct; 30(5):482-5. PubMed ID: 17803743
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of canine MDR1 mRNA: its abundance in drug resistant cell lines and in vivo.
    Steingold SF; Sharp NJ; McGahan MC; Hughes CS; Dunn SE; Page RL
    Anticancer Res; 1998; 18(1A):393-400. PubMed ID: 9568108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.
    Neff MW; Robertson KR; Wong AK; Safra N; Broman KW; Slatkin M; Mealey KL; Pedersen NC
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11725-30. PubMed ID: 15289602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical observations in collies given ivermectin orally.
    Paul AJ; Tranquilli WJ; Seward RL; Todd KS; DiPietro JA
    Am J Vet Res; 1987 Apr; 48(4):684-5. PubMed ID: 3592367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of ABCB1:c.227_230delATAG mutation in affected dog breeds from European countries.
    Firdova Z; Turnova E; Bielikova M; Turna J; Dudas A
    Res Vet Sci; 2016 Jun; 106():89-92. PubMed ID: 27234542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response rate to a single dose of vinblastine administered to dogs with treatment-naive multicentric lymphoma.
    Harding K; Bergman N; Smith A; Lindley S; Szivek A; Milner R; Brawner W; Lejeune A
    Vet Comp Oncol; 2018 Dec; 16(4):636-641. PubMed ID: 30117260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.